Looking at a mixed start for the COVID VACCINE stocks this morning with 10 pointing to a higher opening with IBIO set to lead the pack.
NantKwest (NK) should have been included from the outset given its covid vaccine program. This makes 25 COVID VACCINE stocks in the Index.
The race is on:
If there really is an 80-90% chance of success for Moderna's vaccine, this stock is worth a lot more than $60:
Phase 2 test for potential oral treatment for COVID: Newly listed company (IMMUNIC - IMUX):
No comments:
Post a Comment